Please assess the completion status of the following clinical trial:

Trial Title: Behavioral Therapy Plus Naltrexone for Alcoholism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Meets criteria for alcohol dependence, has not had more than one previous inpatient medical detoxification.~* Consumes on average five standard drinks per day.~* Able to maintain sobriety for five days (with or without the aid of detoxification medications) as determined by self-report, collateral report, and breathalyzer measurements.~* Able to read and understand questionnaires and informed consent.~* Lives within 50 miles of the study site.~Exclusion Criteria:~* Currently meets criteria for any other psychoactive substance dependency disorder.~* Ever abused opiates.~* Used psychoactive substance abuse, except marijuana, within the last 30 days as evidenced by patient report, collateral report, and urine drug screen.~* Meets criteria for disorders of major depression, panic disorder, obsessive-compulsive disorder, post-traumatic stress syndrome, bipolar affective disorder, schizophrenia, or any other psychotic disorder or organic mental disorder.~* Meets criteria for dissociate disorder or eating disorders.~* Has current suicidal or homicidal ideation.~* Need for maintenance or acute treatment with any psychoactive medication including antiseizure medications.~* Current use of disulfiram (Antabuse).~* Clinically significant medical problems that would impair participation or limit medication ingestion.~* Hepatocellular disease.~* Sexually active females of child bearing potential who are pregnant, nursing, or who are not using a reliable form of birth control.~* Have current charges pending for a violent crime.~* Does not have a stable living situation and a reliable source of collateral reporting.~* Has taken an opiate antagonist drug in the last month.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).